Cargando…

Volume Matters in Ultrasound-Guided Perineural Dextrose Injection for Carpal Tunnel Syndrome: A Randomized, Double-Blinded, Three-Arm Trial

Ultrasound-guided perineural dextrose injection (PDI) has been reported effective for carpal tunnel syndrome (CTS). Higher volume of injectate may reduce adhesion of median nerve from other tissues, but volume-dependent effects of PDI in CTS remain unknown. We aimed to investigate whether PDI with d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Meng-Ting, Liao, Chun-Li, Hsiao, Ming-Yen, Hsueh, Hsueh-Wen, Chao, Chi-Chao, Wu, Chueh-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773892/
https://www.ncbi.nlm.nih.gov/pubmed/33391002
http://dx.doi.org/10.3389/fphar.2020.625830
_version_ 1783630146400419840
author Lin, Meng-Ting
Liao, Chun-Li
Hsiao, Ming-Yen
Hsueh, Hsueh-Wen
Chao, Chi-Chao
Wu, Chueh-Hung
author_facet Lin, Meng-Ting
Liao, Chun-Li
Hsiao, Ming-Yen
Hsueh, Hsueh-Wen
Chao, Chi-Chao
Wu, Chueh-Hung
author_sort Lin, Meng-Ting
collection PubMed
description Ultrasound-guided perineural dextrose injection (PDI) has been reported effective for carpal tunnel syndrome (CTS). Higher volume of injectate may reduce adhesion of median nerve from other tissues, but volume-dependent effects of PDI in CTS remain unknown. We aimed to investigate whether PDI with different injectate volumes had different effects for CTS participants. In this randomized, double-blinded, three-arm trial, 63 wrists diagnosed with CTS were randomized into three groups that received ultrasound-guided PDI with either 1, 2 or 4 ml of 5% dextrose water. All participants finished this study. Primary outcome as visual analog scale (VAS) and secondary outcomes including Boston Carpal Tunnel Questionnaire (BCTQ), Disability of the Arm, Shoulder and Hand score (QuickDASH), electrophysiological studies and cross-sectional area (CSA) of the median nerve at carpal tunnel inlet were assessed before and after PDI at the 1st, 4th, 12th and 24th weeks. For within-group analysis, all three groups (21 participants, each) revealed significant improvement from baseline in VAS, BCTQ and QuickDASH at the 1st, 4th, 12th and 24th weeks. For between-group analysis, 4 ml-group yielded better VAS reduction at the 4th and 12th weeks as well as improvement of BCTQ and QuickDASH at the 1st, 4th, and 12th weeks, compared to other groups. No significant between-group differences were observed in electrophysiological studies or median nerve CSA at any follow-up time points. There were no severe complications in this trial, and transient minor adverse effects occurred equally in the three groups. In conclusion, ultrasound-guided PDI with 4 ml of 5% dextrose provided better efficacy than with 1 and 2 ml based on symptom relief and functional improvement for CTS at the 1st, 4th, and 12th week post-injection, with no reports of severe adverse effects. There was no significant difference between the three groups at the 24th-week post-injection follow-up. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT03598322.
format Online
Article
Text
id pubmed-7773892
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77738922021-01-01 Volume Matters in Ultrasound-Guided Perineural Dextrose Injection for Carpal Tunnel Syndrome: A Randomized, Double-Blinded, Three-Arm Trial Lin, Meng-Ting Liao, Chun-Li Hsiao, Ming-Yen Hsueh, Hsueh-Wen Chao, Chi-Chao Wu, Chueh-Hung Front Pharmacol Clinical Trial Ultrasound-guided perineural dextrose injection (PDI) has been reported effective for carpal tunnel syndrome (CTS). Higher volume of injectate may reduce adhesion of median nerve from other tissues, but volume-dependent effects of PDI in CTS remain unknown. We aimed to investigate whether PDI with different injectate volumes had different effects for CTS participants. In this randomized, double-blinded, three-arm trial, 63 wrists diagnosed with CTS were randomized into three groups that received ultrasound-guided PDI with either 1, 2 or 4 ml of 5% dextrose water. All participants finished this study. Primary outcome as visual analog scale (VAS) and secondary outcomes including Boston Carpal Tunnel Questionnaire (BCTQ), Disability of the Arm, Shoulder and Hand score (QuickDASH), electrophysiological studies and cross-sectional area (CSA) of the median nerve at carpal tunnel inlet were assessed before and after PDI at the 1st, 4th, 12th and 24th weeks. For within-group analysis, all three groups (21 participants, each) revealed significant improvement from baseline in VAS, BCTQ and QuickDASH at the 1st, 4th, 12th and 24th weeks. For between-group analysis, 4 ml-group yielded better VAS reduction at the 4th and 12th weeks as well as improvement of BCTQ and QuickDASH at the 1st, 4th, and 12th weeks, compared to other groups. No significant between-group differences were observed in electrophysiological studies or median nerve CSA at any follow-up time points. There were no severe complications in this trial, and transient minor adverse effects occurred equally in the three groups. In conclusion, ultrasound-guided PDI with 4 ml of 5% dextrose provided better efficacy than with 1 and 2 ml based on symptom relief and functional improvement for CTS at the 1st, 4th, and 12th week post-injection, with no reports of severe adverse effects. There was no significant difference between the three groups at the 24th-week post-injection follow-up. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT03598322. Frontiers Media S.A. 2020-12-17 /pmc/articles/PMC7773892/ /pubmed/33391002 http://dx.doi.org/10.3389/fphar.2020.625830 Text en Copyright © Lin, Liao, Hsiao, Hsueh, Chao and Wu http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Clinical Trial
Lin, Meng-Ting
Liao, Chun-Li
Hsiao, Ming-Yen
Hsueh, Hsueh-Wen
Chao, Chi-Chao
Wu, Chueh-Hung
Volume Matters in Ultrasound-Guided Perineural Dextrose Injection for Carpal Tunnel Syndrome: A Randomized, Double-Blinded, Three-Arm Trial
title Volume Matters in Ultrasound-Guided Perineural Dextrose Injection for Carpal Tunnel Syndrome: A Randomized, Double-Blinded, Three-Arm Trial
title_full Volume Matters in Ultrasound-Guided Perineural Dextrose Injection for Carpal Tunnel Syndrome: A Randomized, Double-Blinded, Three-Arm Trial
title_fullStr Volume Matters in Ultrasound-Guided Perineural Dextrose Injection for Carpal Tunnel Syndrome: A Randomized, Double-Blinded, Three-Arm Trial
title_full_unstemmed Volume Matters in Ultrasound-Guided Perineural Dextrose Injection for Carpal Tunnel Syndrome: A Randomized, Double-Blinded, Three-Arm Trial
title_short Volume Matters in Ultrasound-Guided Perineural Dextrose Injection for Carpal Tunnel Syndrome: A Randomized, Double-Blinded, Three-Arm Trial
title_sort volume matters in ultrasound-guided perineural dextrose injection for carpal tunnel syndrome: a randomized, double-blinded, three-arm trial
topic Clinical Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773892/
https://www.ncbi.nlm.nih.gov/pubmed/33391002
http://dx.doi.org/10.3389/fphar.2020.625830
work_keys_str_mv AT linmengting volumemattersinultrasoundguidedperineuraldextroseinjectionforcarpaltunnelsyndromearandomizeddoubleblindedthreearmtrial
AT liaochunli volumemattersinultrasoundguidedperineuraldextroseinjectionforcarpaltunnelsyndromearandomizeddoubleblindedthreearmtrial
AT hsiaomingyen volumemattersinultrasoundguidedperineuraldextroseinjectionforcarpaltunnelsyndromearandomizeddoubleblindedthreearmtrial
AT hsuehhsuehwen volumemattersinultrasoundguidedperineuraldextroseinjectionforcarpaltunnelsyndromearandomizeddoubleblindedthreearmtrial
AT chaochichao volumemattersinultrasoundguidedperineuraldextroseinjectionforcarpaltunnelsyndromearandomizeddoubleblindedthreearmtrial
AT wuchuehhung volumemattersinultrasoundguidedperineuraldextroseinjectionforcarpaltunnelsyndromearandomizeddoubleblindedthreearmtrial